Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Glycyrrhizin (GL) has been used in Japan to treat patients with chronic viral hepatitis, as an anti-inflammatory drug to reduce serum alanine aminotransferase levels. GL is also known to exhibit various biological activities, including anti-viral effects, but the anti-hepatitis C virus (HCV) effect of GL remains to be clarified. In this study, we demonstrated that GL treatment of HCV-infected Huh7 cells caused a reduction of infectious HCV production using cell culture-produced HCV (HCVcc). To determine the target step in the HCV lifecycle of GL, we used HCV pseudoparticles (HCVpp), replicon, and HCVcc systems. Significant suppressions of viral entry and replication steps were not observed. Interestingly, extracellular infectivity was decreased, and intracellular infectivity was increased. By immunofluorescence and electron microscopic analysis of GL treated cells, HCV core antigens and electron-dense particles had accumulated on endoplasmic reticulum attached to lipid droplet (LD), respectively, which is thought to act as platforms for HCV assembly. Furthermore, the amount of HCV core antigen in LD fraction increased. Taken together, these results suggest that GL inhibits release of infectious HCV particles. GL is known to have an inhibitory effect on phospholipase A2 (PLA2). We found that group 1B PLA2 (PLA2G1B) inhibitor also decreased HCV release, suggesting that suppression of virus release by GL treatment may be due to its inhibitory effect on PLA2G1B. Finally, we demonstrated that combination treatment with GL augmented IFN-induced reduction of virus in the HCVcc system. GL is identified as a novel anti-HCV agent that targets infectious virus particle release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817 · cited 1×
“PLA2 family proteins have been known as lipid-signaling molecules, inducing inflammation [43].”
BackgroundPhospholipase A2 structure/function, mechanism, and signaling
Burke, J. E., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800033-jlr200 · Cited by 933
Cited by
The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb
Wang, L., Yang, R., Yuan, B., Liu, Y., & Liu, C. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.005 · Cited by 590
Bailly, C., & Vergoten, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107618 · Cited by 301
Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
Li, J.-Y., Cao, H.-Y., Liu, P., Cheng, G.-H., & Sun, M.-Y. (2014) · BioMed Research International · doi:10.1155/2014/872139 · Cited by 271
Hong, M., Li, S., Tan, H., Wang, N., Tsao, S.-W., & Feng, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226126 · Cited by 194
“Recently, glycyrrhizin has been found to suppress HCV particle release as well as the activity of phospholipase A2 (PLA2) [24].”
BackgroundWang, C., Chen, L., Xu, C., Shi, J., Chen, S., Tan, M., Chen, J., Zou, L., Chen, C., Liu, Z., et al. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500020 · Cited by 115
Metadata
- Authors
- Matsumoto, Y., Matsuura, T., Aoyagi, H., Matsuda, M., Hmwe, S. S., Date, T., Watanabe, N., Watashi, K., Suzuki, R., Ichinose, S., Wake, K., Suzuki, T., Miyamura, T., Wakita, T., & Aizaki, H.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-18
- Volume
- 8
- Issue
- 7
- Pages
- e68992
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2091757219
- Cited by
- 138
- References
- 2
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro. https://app.cochat.ai/papers/10.1371/journal.pone.0068992
- The paper
- Matsumoto, Y., Matsuura, T., Aoyagi, H., Matsuda, M., Hmwe, S. S., Date, T., Watanabe, N., Watashi, K., Suzuki, R., Ichinose, S., Wake, K., Suzuki, T., Miyamura, T., Wakita, T., & Aizaki, H. (2013). Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro. PLoS ONE. https://doi.org/10.1371/journal.pone.0068992
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.